Article Details

Pfizer Agrees to Pay $345 Million to Resolve EpiPen Anti-Competitive Allegations - Policy & Medicine

Retrieved on: 2021-08-18 08:03:45

Tags for this article:

Click the tags to see associated articles and topics

Pfizer Agrees to Pay $345 Million to Resolve EpiPen Anti-Competitive Allegations - Policy & Medicine. View article details on hiswai:

Excerpt

In the court filing, Pfizer notes that not only has the company not engaged in any wrongdoing as alleged, but also deny liability for any of the claims alleged ...

Article found on: www.policymed.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up